These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32253085)
1. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting. Kirby J; Mousa N J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a community pharmacy-based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing. Klepser DG; Klepser ME; Murry JS; Borden H; Olsen KM J Am Pharm Assoc (2003); 2019; 59(6):872-879. PubMed ID: 31474527 [TBL] [Abstract][Full Text] [Related]
3. Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting. Klepser DG; Klepser ME; Smith JK; Dering-Anderson AM; Nelson M; Pohren LE Res Social Adm Pharm; 2018 Apr; 14(4):356-359. PubMed ID: 28479019 [TBL] [Abstract][Full Text] [Related]
4. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy. Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199 [TBL] [Abstract][Full Text] [Related]
5. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program. Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440 [TBL] [Abstract][Full Text] [Related]
6. Evaluating advanced pharmacy technician roles in the provision of point-of-care testing. Hill H; Cardosi L; Henson L; Wasson M; Fountain M; Desselle S; Hohmeier KC J Am Pharm Assoc (2003); 2020; 60(4):e64-e69. PubMed ID: 32217084 [TBL] [Abstract][Full Text] [Related]
7. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study. Munger MA; Walsh M; Godin J; Feehan M Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045 [TBL] [Abstract][Full Text] [Related]
8. Point-of-care C-reactive protein testing to support the management of respiratory tract infections in community pharmacy: A feasibility study. Sim TF; Chalmers L; Czarniak P; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B Res Social Adm Pharm; 2021 Oct; 17(10):1719-1726. PubMed ID: 33500197 [TBL] [Abstract][Full Text] [Related]
9. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists. Steltenpohl EA; Barry BK; Coley KC; McGivney MS; Olenak JL; Berenbrok LA J Pharm Pract; 2018 Dec; 31(6):629-635. PubMed ID: 29034781 [TBL] [Abstract][Full Text] [Related]
10. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases. Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479 [TBL] [Abstract][Full Text] [Related]
11. Implementation of a medication therapy management program in a primary care clinic. Bowers BL; Heffern C; Billings S J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. Klepser ME; Klepser DG; Dering-Anderson AM; Morse JA; Smith JK; Klepser SA J Am Pharm Assoc (2003); 2016 Jan; 56(1):14-21. PubMed ID: 26802915 [TBL] [Abstract][Full Text] [Related]
13. Community pharmacist-physician collaborative streptococcal pharyngitis management program. Klepser DG; Klepser ME; Dering-Anderson AM; Morse JA; Smith JK; Klepser SA J Am Pharm Assoc (2003); 2016; 56(3):323-329.e1. PubMed ID: 27067554 [TBL] [Abstract][Full Text] [Related]
14. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931 [TBL] [Abstract][Full Text] [Related]
15. Observation of a Pharmacist-Conducted Group A Streptococcal Pharyngitis Point-of-Care Test: A Time and Motion Study. Corn CE; Klepser DG; Dering-Anderson AM; Brown TG; Klepser ME; Smith JK J Pharm Pract; 2018 Jun; 31(3):284-291. PubMed ID: 28553774 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Wibowo Y; Parsons R; Sunderland B; Hughes J Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291 [TBL] [Abstract][Full Text] [Related]
17. Community pharmacy-based point-of-care testing: A case study of pharmacist-physician collaborative working relationships. Bacci JL; Klepser D; Tilley H; Smith JK; Klepser ME Res Social Adm Pharm; 2018 Jan; 14(1):112-115. PubMed ID: 28082033 [TBL] [Abstract][Full Text] [Related]
18. Pharmacist intervention in colorectal cancer screening initiative. Holle LM; Levine J; Buckley T; White CM; White C; Hadfield MJ J Am Pharm Assoc (2003); 2020; 60(4):e109-e116. PubMed ID: 32197754 [TBL] [Abstract][Full Text] [Related]
19. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project. Dong BJ; Lopez M; Cocohoba J J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784 [TBL] [Abstract][Full Text] [Related]
20. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies. Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]